Tata India Pharma & Healthcare Fund vs Mirae Asset Healthcare Fund compare
Tata India Pharma & Healthcare Fund-Regular Plan-Growth
Mirae Asset Healthcare Fund -Regular Growth
Chart Comparison
Overview
Scheme Name | Tata India Pharma & Healthcare Fund-Regular Plan-Growth | Mirae Asset Healthcare Fund -Regular Growth |
---|---|---|
Fund | Tata India Pharma & Healthcare Fund-Regular Plan-Growth | Mirae Asset Healthcare Fund -Regular Growth |
Investment Plan | Growth | Growth |
Level of Risk | Very High | Very High |
Asset Size (Cr) | ₹1339 Cr | ₹2908 Cr |
Min Investment | ₹5000 | ₹5000 |
Min SIP Invesment | ₹100 | ₹500 |
Min Addl Investment | ₹1000 | ₹1000 |
Launch Date | 28 Dec 2015 | 02 Jul 2018 |
Category | Pharma & Healthcare | Pharma & Healthcare |
Fund Type | Open Ended | Open Ended |
Benchmark | Nifty Pharma TRI | BSE Healthcare |
Turn Over | 26.49% | 15% |
Expense Ratio | 2.14 | 1.92 |
Manager | Meeta Shetty | Vrijesh Kasera |
ISIN Code | INF277K016A9 | INF769K01EA2 |
Exits Load | Tata India Pharma & Heathcare Fund - Growth charges 0.25% of sell value; if fund sold before 30 days. There are no other charges./365 | Mirae Asset Healthcare Fund - Growth charges 1.0% of sell value; if fund sold before 365 days. There are no other charges./365 |
Trailing Lumpsum Returns
Scheme Name | Tata India Pharma & Healthcare Fund-Regular Plan-Growth | Mirae Asset Healthcare Fund -Regular Growth |
---|---|---|
1 Month | 1.25% | -1.68% |
6 Month | 11.8% | 10.87% |
1 Year | 4.55% | 4.15% |
3 Year | 24.03% | 21.77% |
5 Year | 19.03% | 18.7% |
SIP Return Analysis
Scheme Name | Tata India Pharma & Healthcare Fund-Regular Plan-Growth | Mirae Asset Healthcare Fund -Regular Growth |
---|---|---|
6 Month | 5.89% | 5.11% |
1 Year | 8.92% | 8.48% |
3 Year | 23.85% | 23.12% |
5 Year | 19.7% | 18.82% |
Rolling Lumpsum Returns
Scheme Name | Tata India Pharma & Healthcare Fund-Regular Plan-Growth | Mirae Asset Healthcare Fund -Regular Growth |
---|---|---|
1 Year | 10.55% | 21.43% |
3 Year | 18.34% | 19.12% |
5 Year | 15.18% | 23.9% |
Risk Management
Scheme Name | Tata India Pharma & Healthcare Fund-Regular Plan-Growth | Mirae Asset Healthcare Fund -Regular Growth |
---|---|---|
Standard Deviation | 15.78% | 16.00% |
Sharp | 1.05% | 0.97% |
Beta | 0.99% | 1.00% |
Alpha | -0.95% | -2.15% |
Fund Managers
Scheme Name | Tata India Pharma & Healthcare Fund-Regular Plan-Growth | Mirae Asset Healthcare Fund -Regular Growth |
---|---|---|
Name | Meeta Shetty | Vrijesh Kasera |
Total AUM | ₹17847 Cr | ₹12061 Cr |
Funds Managed | 5 | 4 |
Tata India Pharma & Healthcare Fund-Regular Plan-Growth | Mirae Asset Healthcare Fund -Regular Growth |
Market Cap
Scheme Name |
Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
Mirae Asset Healthcare Fund -Regular Growth |
---|---|---|
Others | 8.59 | 4.85 |
Large Cap | 27.92 | 31.78 |
Mid Cap | 32.96 | 38.01 |
Small Cap | 30.52 | 25.36 |
Sector Allocation
Scheme Name |
Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
Mirae Asset Healthcare Fund -Regular Growth |
---|---|---|
Others | 6.22 | 0.37 |
Basic Materials | 0.46 | 1.33 |
Healthcare | 91.69 | 98.29 |
Financial Services | 1.63 | - |
Top Comparisons
SBI Magnum Gilt Fund - Growth - PF (Regular) Option
3Y Returns7.49%
DSP Gilt Fund - Regular Plan - Growth
3Y Returns7.26%
BANDHAN Government Securities Fund - IP - Regular Plan - Growth
3Y Returns6.62%
UTI - Gilt Fund - Regular Plan - Growth Option
3Y Returns7.01%
SBI Short Horizon Debt Fund - Ultra Short Term Fund - Institutional Plan - Growth
3Y Returns6.99%
Mirae Asset Ultra Short Duration Fund Regular Growth
3Y Returns7.26%
Nippon India Consumption Fund-Growth Plan-Growth Option
3Y Returns17.51%
Sundaram Consumption Fund(Formerly Known as Sundaram Rural and Consumption Fund Regular Plan - Growth)
3Y Returns16.74%